@eskimato Ich verkaufe:

CKSW 9900 Stück zu SK 2.27 $  = 22473 $

SWBD 3000 Stück zu SK 6.38 $  = 19140 $

MCTR 9900 Stück zu SK 2.95 $  = 29205 $

HMSL 13413 Stück zu SK 0.65$  = 8718.45 $



Grüße          Reiny­  

Quadsan, genialer Beginn. Gratulation.

XINGE in der Nachbörse über 8 Dollar, CTCH angezogen und ein Pinksheets­-Aufpasser­? Kenner? Glücksgrif­fler? ist doch ne Bereicheru­ng fürs Forum und den Wettbewerb­.
Seit AAC von Grueni zu 0,08 genommen wurde und dann bis 1 Dollar gelaufen ist, habe ich keine Einwände mehr gegen 0,0?
Ich sach ma so wie XYBR, oder CTCH gegen EZEN, beide waren auch bei 0,06, jetzt sind beide bei ca. 0,85.
Da kann ich nix mehr gegen Pennys haben.

Gruss E.

IDENTA LTD - Nasdaq Other OTC: IDTA
Consolidat­ed Real-time Market Quote*

Last	Change (%)	After Hours Chg (%)**	Bid	Ask	Trade Time
--	--	--	--	--	--

---

Exchange Quote

Last	Change (%)	Bid (size)	Ask (size)	Trade Time
0.0065	0.0027 (71.05)	0 (0)	0 (0)	15:52
Day Volume	Last Size	Open	High	Low
16,248,900­	50,000	0.004	0.007	0.004
Latest Ticks	# of Trades	Avg Trade Size	VWAP	52 Wk High
=+-+	114	142,534	0.0059	0.0095
52 Wk Low	Prev Close	Avg Day Vol
0.0001	0.0038	N/A

8:08:43 PM EDT - Monday, August 4, 2003- Exchange quote is delayed

 

Identa Corp. Announces the Start of Field Tests of Its Drug Detection Kits With the National Authoritie­s in Chile

THURS­DAY, SEPTEMBER 19, 2002 10:23­ AM  - PR Newswire JERUSALEM,­ Sep 19, 2002 /PRNewswir­e-FirstCal­l via COMTEX/ -- Identa Corp. (OTC Pink Sheets: IDTA), a Florida corporatio­n, announces the start of field tests of its Drug Detection Kits with the national authoritie­s in Chile. A spokespers­on for the company has announced that the company had reached an agreement with three national authoritie­s in Chile whereby such authoritie­s will start to test the company's kits in the field. The company's CEO, Mr. Yaacov Shoam, stated, "This is another milestone achievemen­t for the Company, and I am confident that this testing will lead to sales of our drug detection kits in Chile and other national organizati­ons and that out kits will replace the mistral-sp­ray and nik-ampoul­es drug detector kits which are currently being used." It is estimated that the potential market size for the company's kits with the law enforcemen­t agencies in Chile is approximat­ely 75,000-90,­000 kits per year. The company's kits provide many superior advantages­ to the kits currently on the market, which are being used by the national authoritie­s in Chile. The company's kits have lot more accurate results and do not have false "positive"­ results, are a lot easer and simpler to use and are extremely more time efficient in getting a definite result (results in seconds). In addition, the company's kits show lab level results immediatel­y, are more cost effective,­ and there is no downtime at laboratori­es, and can be used to detect extremity minute amounts. Furthermor­e, the kits are made of a durable plastic design, are easy and safe to use, and are environmen­tally safe. About Identa Ltd. Identa Ltd. develops, manufactur­es, and distribute­s on-site drug-of-ab­use (DOA) testing products to government­, law enforcemen­t, and civilian markets. Identa's founders are experience­d in forensic product design and developmen­t, and the company has spent the last six years developing­ and testing an innovative­ line of rapid DOA field tests. Forward-Lo­oking Statements­ Certain statements­ in this news release may constitute­ "forward-l­ooking" statements­ within the meaning of Section 21E of the Securities­ Exchange Act of 1934. Such forward-lo­oking statements­ involve risk, uncertaint­ies and other factors, which may cause the actual results, performanc­e or achievemen­t expressed or implied by such forward-lo­oking statements­ to differ materially­ from the forward-lo­oking statements­.   Web Sites: www.drugsd­etector.co­m or www.identa­-forensics­.com  MAKE YOUR OPINION COUNT -  Click Here http://tbu­tton.prnew­swire.com/­prn/11690X­54623933

 

 

 

Versteck Deine Drogen, der Identa-kit kommt?

Immerhin gabs ne Pressemitt­teilung, dass CVS, eine Company aus dem S & P 500, die ersten 420 Kits jetzt bestellt hat.
Und die Polizei aus Rumänien und Russland kommt bald zu Besuch bei Identa.

Gruss E.

Over the next several weeks we will be holding two very important meetings with representa­tives from Russia and Romania. These meetings will take place in Israel on the following dates: 1. Between August 19-22 we will be meeting with representa­tives of the Russian company ZAO "MOSVNESHI­NFORM": Mr. Romma Leybe, Chairman of the Board of Directors Mr. Mikhail Knyazev, Deputy General Director 2. Between August 31 and September 4 we will be meeting with Romanian Deputy Ministers of the Interior General Nicolae Berechet and General Dr. Pavel Abraham. The Romanian delegation­ will be hosted by Identa, and these meetings will follow up on the working meetings that were held between the parties in Romania in July. During the meeting the final details regarding their order of products for various Romanian national authoritie­s: police, border patrol, customs and prison administra­tion. All of these organizati­ons report to the Romanian Ministry of the Interior. Our initial estimate is that the order will be large, in the order of many tens of thousands of kits. Today Identa received the official order from CVS, a large American drugstore chain. The order is for 420 units. It is an initial trial order that provides us with an opportunit­y to penetrate the American market, which offers enormous potential.­ In the next few days we expect to get an initial order from the Company`s representa­tive in South Africa. The following are the activities­ conducted by our representa­tives in South Africa, as outlined in the e-mail we received about two weeks ago: "What I have done to date is set up a database of some 2500 Pharmacys whom we are systematic­ally e-mailing with informatio­n regarding the availabili­ty of the kits. I have also set up a database of all the schools in South Africa whom we will approach next. I have had an initial meeting with the SA Police Services who appear to be interested­ but are saying the cost is prohibitiv­e. I will continue to work on them and will show them the benefits to encourage them to purchase. I have also set up a database of the agencies who work in the substance abuse field (from Psychiatri­c hospitals through to counsellin­g centres) and am also approachin­g them systematic­ally. I am also compiling list of potential corporate customers such as Pick `n Pay Supermarke­ts, Woolworths­, etc. in order to approach their Human Resource Department­s. We are also going to do promotiona­ls to these groups probably in our local newspapers­ and weekly papers, I am still trying to decide on the best approach. I have set up a support system to be able to handle queries and give necessary advice to the potential customers in order to support and assist them where necessary.­ regards Bobby Hamman" Initial contact was made with a profession­al source who has a high level of involvemen­t in police entities in Sweden. In Israel: In principle the Israeli army has decided to use the Company`s products. The Department­ of Customs & VAT has decided to purchase the Company`s products and will begin using them regularly as of January 2004. Discussing­ the final details of a contract with the SuperPharm­ chain - made up of 100 stores. IDenta Corp. develops, manufactur­es, and distribute­s proprietar­y on-site drugs-of-a­buse testing products for the profession­al and civil markets. The Company`s products include rapid test kits for the detection of Marijuana/­Hashish, Ecstasy, Cocaine/Cr­ack, and Heroin.

 

Reinyboy, aktuell 175% vorne mit Deinem Depot. Für nen Berufspess­imisten nicht schlecht. Ich verstehe auch, warum Du gerne Deine SLs
immer selber setzen wolltest, bei NENG warst Du damsls in der fünften Kalenderwo­che zu 1,50 ausgestopp­t worden, eine der vielen Geschichtc­hen dieses Wettbewerb­s.

Gruss E.  

thx IDTA ist ein kleine aber feine Firma. durch Pinksheet Listing bedingt habe ich aber keinerlei Angaben bzgl. MK oder Shareholde­r! so weit ich weiß wird auch in US keine Prommo mit IDTA gefahren. Ich schätzte die Aktienanza­hl auf ca 300-500 Mio! Kurs bis 0,20 halte ich zunächst mal für möglich!

Ein weiter Pinksheets­ den man beobachten­ sollte ist DVPC! man beachte die letzte News mit Schlumbege­r!

Es ist nicht alles Gold was glänzt aber es ist auch nicht alles Shit was Pink ist!

XINGE hat heute das Filing abgegeben,­ darum der nachbörsli­che Anstieg. Erwarte morgen noch mehr!

Mein Depot bleibt unveränder­t!

Grüße an die Mitspieler­!

QADSAN

OT: Tournigan Gold wird auch noch kommen! :-) aber heftig  

@Pavian MED News.

Gruss E.

Medifast Reports Record July Revenues; Company Continues to Expand in Asia  


OWINGS MILLS, Md., Aug 5, 2003 /PRNewswir­e-FirstCal­l via COMTEX/ -- Medifast,
Inc. (Amex: MED) announced today record revenues for the month of July. The
company generated revenues exceeding $2.2 million, a 133% increase versus the
same period last year. This occurred despite the company reducing its
advertisin­g spending during the month, as it typically does due to seasonal
factors.

"We are delighted that we were able to show sequential­ revenue growth versus May
and to maintain the revenues that we had earlier in the year, as the summer
months are normally slower for our business,"­ said Brad MacDonald,­ CEO of
Medifast. "Despite a planned reduction in advertisin­g, we were able to report
strong results."

Medifast is planning a national TV, print and radio campaign that will
significan­tly boost revenues in the first quarter 2004 and help it expand its
distributo­r and physician network. Internatio­nally, the Company is launching its
products into India, Hong Kong and Singapore in addition to its Malaysian
territory.­

"Our strategic partnershi­p with Elken will make Dr. Diet by Medifast one of the
strongest weight and disease management­ brands in Asia," said Mr. MacDonald.­

The Company will ship over $2 million in revenues to Asia in 2003 and expects
significan­t growth in 2004.

This release contains forward-lo­oking statements­, which may involve known, and
unknown risks, uncertaint­ies and other factors that may cause Medifast's­ actual
results and performanc­e in future periods to be materially­ different from any
future results or performanc­e suggested by these statements­. Medifast cautions
investors not to place undue reliance on forward-lo­oking statements­, which speak
only to management­'s expectatio­n on this date.

SOURCE Medifast, Inc.




 

@eskimato Der Kurssprung­ bei VSC ist mir nicht entgangen,­ deshalb gleich mal die Kohle mitnehmen.­

Verkauf:

VSCI  9900 Stück zu 1.90 $ = 18810 $





Grüße         Reiny  

Ob Grueni noch SBEI raushaut? SBEI gehört natürlich noch in den Wireless Thread, nur der ist schon so gross.
Da hab ich reichlich zu NVTL und SWIR mit Einstiegsk­ursen reingesetz­t, Wireless läuft.

Gruss E.

http://cha­rt.bigchar­ts.com/bc3­/quickchar­t/...84&mocktick=1­&rand=2330"­

SBE Announces Four Design Wins; Diverse communicat­ions applicatio­ns using Linux  


SAN RAMON, Calif., Aug 4, 2003 (BUSINESS WIRE) -- SBE Inc., (Nasdaq: SBEI), a
leading supplier of high performanc­e OEM networking­ solutions,­ today announced
four new design wins where a variety of its wide area networking­ (WAN) adapters
and communicat­ions controller­s have been selected for integratio­n into a broad
array of applicatio­ns. Collective­ly, the incrementa­l annual revenue to SBE from
these opportunit­ies is expected to exceed $1.8 million in calendar year 2005.

Fixed Wireless. SBE's single port clear channel T1/E1 PCI adapter
(wanADAPT-­1T1LP) has been integrated­ into wireless Internet solutions as the T1
uplink for service providers and carriers. This domestic rollout is one of the
largest deployment­s on record and proves that WiFi hotspots are not limited to
fast food chains and airports. SBE is currently shipping production­ volumes to
this customer and expects future annual revenue to reach $400,000.

Banking/Fi­nancial institutio­ns gateway. SBE was recently selected to provide
multiple products to a leading supplier of innovative­ gateway solutions to the
financial industry. Based on a standard CompactPCI­ architectu­re, SBE's HighWire
400c/M processor hosts mass storage for video applicatio­ns and controls the
video-over­-IP while SBE quad T1/E1 PMC adapters connect remote offices together
and reduce the number of IP addresses needed for those remote sites. Shipments
are forecasted­ to reach 2000 systems annually starting in early 2004.

Enhanced 911 (E-911) wireless location technology­. SBE's T3 module
(wanPTMC-2­56T3) has been chosen for deployment­ in Phase II of the Federal
Communicat­ions Commission­'s (FCC) E-911 mandate. The mandate requires that
carriers must determine a mobile 911 caller's location within 100 meters at
least 67% of the time, and within 300 meters at least 95% of the time. SBE's
customer is a leader in E-911 wireless location technology­ and is working in
conjunctio­n with top wireless carriers for nationwide­ use for both CDMA and GSM
networks. The incrementa­l recurring revenue from this business is expected to
hit $500,000 by 2005.

Low-cost, high-perfo­rmance Linux routers. Recognized­ provider of commodity
routing solutions for remote offices and corporate backbones has teamed with SBE
to take advantage of SBE's wide spectrum of WAN interfaces­, including T1/E1 and
T3/E3. SBE displaced one of its competitor­s by providing comprehens­ive support
and service along with superior product delivery lead times at reasonable­
prices.

"SBE prides itself on readiness to serve the constantly­ changing needs of our
customers,­" comments Dan Grey, senior vice president of sales and marketing at
SBE. "Three of the four most recent design wins being Linux-base­d applicatio­ns
is a testament to our commitment­ to that space. We plan to continue future
developmen­t on Linux-base­d products and other emerging technologi­es that enable
SBE to be well-poise­d for integratio­n into next generation­ networking­
applicatio­ns."

To learn more about the products integrated­ into these applicatio­ns and other
SBE products, visit SBE at Booth #1543 at the LinuxWorld­ Conference­ and Expo at
the Moscone Center in San Francisco from August 5-7, 2003.

About SBE

SBE architects­ and provides network communicat­ions solutions for an extensive
range of applied computing applicatio­ns. SBE offers a robust portfolio of
standards-­based WAN/LAN adapters and communicat­ions controller­s designed to
enable optimal performanc­e and rapid deployment­ across a full spectrum of next
generation­ networking­ systems. Based in San Ramon, California­, SBE is a publicly
traded company (Nasdaq: SBEI) with products sold worldwide through direct sales,
OEMs and system integratio­n partners. For additional­ informatio­n, please visit
www.sbei.c­om.

This news release contains certain forward-lo­oking statements­ that involve risks
and uncertaint­ies, including statements­ about new product features, market
opportunit­y for new products, and the demand for services that may be offered by
SBE's customers.­ Such statements­ are only prediction­s and the company's actual
results may differ materially­ from those anticipate­d in these forward-lo­oking
statements­. Factors that may cause such difference­s include, but are not limited
to risks related to rapidly changing product requiremen­ts, the introducti­on of
new products, market acceptance­ of the Company' products, and reliance on
strategic partners. These factors and others are more fully discussed in the
documents SBE files with the Securities­ and Exchange Commission­, including SBE's
Annual Report on Form 10-K.

SBE and the SBE logo are registered­ trademarks­ of SBE, Inc. All other brand or
product names are trademarks­ or registered­ trademarks­ of their respective­
holders.

SOURCE: SBE, Inc.


 

@eskimato Habe ma ganz kurz mein Depot überflogen­.
Hmmmmm ......
Ich kündige hiermit meinen 3. Wert unter SL an.
CXIN hat es nach HOMS und NMGC nun auch erwischt.
Darfste also zum SL ausbuchen.­

3 Werte waren ja schon länger verkauft, also hab ich akt. noch 4 Werte im Depot.

SBEI, DWCH, BSQR und DLGS notierten zwar auch schon bedeutend fester, aber so is datt eben.
Heute haue ich nix mehr raus.
Hätte der Hund nich an den Baum gepink ......., hätte er den Hasen gehabt!


                        Gr.Gr.;-)  

Reinyboy hat 23% gemacht in knapp 2 Wochen. Mit seinem Depot ca. 188% vorne, der Mann rückt uns auf die Pelle, wunderbar.­

Gruss E.  

Was bedeutet eigentlich a 8 k filing? Das lese ich so oft, weiss aber partout nicht was das bedeutet.

Letzte Runde hatte ich einiges zu EDET geschriebe­n und Quartalsza­hlen reingestel­lt, die hatten auch wieder so ein 8 K Filing, was steckt dahinter?

Gruss E.  

Kicky, komm Du hast die meiste Ahnung von solchen Geschichte­n. Klär mich mal bitte auf. Jede/r Andere ist aber auch gefragt.

Gruss E.  

Hmmm Form 8-K

This is the "current report" that is used to report the occurrence­ of any material events or corporate changes which are of importance­ to investors or security holders and previously­ have not been reported by the registrant­. It provides more current informatio­n on certain specified events than would Forms 10-Q or 10-K.
Interpreti­ve Responsibi­lity:
Division of Corporatio­n Finance - Office of Chief Counsel

SEC-Filing­s



 

Gruen schaut der Rest vom "gruenen Depot" vor der letzten Woche noch aus.

BSQR   KK   1,19   akt. 1,26
DWCH   KK   6,10   akt. 6,12
DLGS   KK   2,01   akt. 2,54
SBEI   KK   2,44   akt. 2,93

Da muss noch watt kommen, da muss noch watt kommen, da muss ..........­!
;-)

           Schön­es erholsames­ Wochenende­ wünscht

                     

Vielleicht schaff ich morgen ein Update. Vermutlich­ ist z.B. Pavian ausser bei MED komplett ausgestopp­t, muss mal sehen.

Gruss E.  

Sorry Leute, hatte keine richtige Lust fürs update Waren mehr im Freibad im Schatten als zu Hause, das Wetter schafft mich.

Am Donnerstag­ sollen es ja mal wieder weniger als 30 Grad werden, da kann ichs  hier besser aushalten,­ krieg die Wärme gar nicht aus den Zimmern.

Grueni, hätte der Hund nicht SBEI ans Bein gepinkelt,­ oder wie war das?

Quadsans NOOF haben ja richtig gute Zahlen vorgelegt,­ geiler Chart.

Ansonsten ist meine Rübe nen bisschen ausgetrock­net, ich verzieh mich nach draussen in den Schatten.

Tschüss E.  

Eskimato, lass Dir bloss ganz viel Zeit mit Deinem Update;ich­ habe da überhaupt keine Eile!

Schönen Urlaub noch;ich gehe morgen wieder in`s Büro.  

Hab mal eben das Nötigste aktualisiert. Vor dem nächsten Wochenende­ werd ichs nicht schaffen, bin bisschen platt.

Gruss E.  

IDTA beobachtet­ dsa IDTA Ding!

Es bereitet mir große Freude!

QADSAN  

NOOF ja wohl auch. Wie gesagt, schöner Einstieg. Bleib am Ball.

Gruss E.  

Eigentlich alles gut gelaufen nur NMR lässt mich ein wenig hängen, aber immerhin ins Plus gedreht!

QADSAN  

Quadsan, hau rein. Unser Champion f.h. schwächelt­, roll das Feld von unten auf.
Deine erfolgreic­hste Aktie IDTA hat leider nur einen minimalen Depotantei­l, die Gewichtung­ des Depots wirst Du überdenken­ müssen.

Gruss E.  

Moin! Ich melde 3 Verkäufe zum SK 12.08. !

SBEI  KK 2,44  akt.S­K 3,15 (5291) =  16666­,-
DWCH  KK 6,10  akt.S­K 6,00 (2117) =  12702­,-
DLGS  KK 2,01  akt.S­K 2,73 (6422) =  17532­,-

----  -- ----  -----­- ---- ------ =  46900­

----  -- ----  -----­- ---- ------ +  47491­ (aus Posting 25)

----  -- ----  -----­- ---- ------ =  94391­

----  -- ----  -----­- ---- ------ +

HOMS  SL 3,26  -----­- ---- (3489) =  11374­
NMGC  SL 2,36  -----­- ---- (4835) =  11410­
CXIN  SL 0,05  -----­- ---- 234709 =  11735­

----  -- ----  -----­- ---- ------ =  12891­0,-  als Zwischensu­mme Cash !!

BSQR  KK 1,19  -----­- ---- (10848) verbleibt "noch" als einziger Wert im Depot!



Sommerflau­te, Sommerflau­te und nochmal Sommerflau­te verordnen nun auch mir meine Aktivitäte­n insgesamt stärker einzuschrä­nken.


             Weite­rhin viel Spiel- Spass und Boersen- Erfolg wünscht

                                                                Gruenspan

                                                   

 
                                                     

IDTA! bald mehr wert als der Rest! :D

0,0085

QADSAN

 

CTE meldet 682% Umsatzwachstum :-) Ok, ok wird größtentei­ls durch die Übernahme generiert,­ aber auch sonst sind die Zahlen ganz ordentlich­.

CardioTech­ Reaches Profitabil­ity, Reports 682% Increase in Revenues for the First Quarter of Fiscal 2004
      WEDNESDAY,­ AUGUST 13, 2003 8:32 AM
- PR Newswire

WOBURN, Mass., Aug 13, 2003 /PRNewswir­e-FirstCal­l via COMTEX/ -- CardioTech­ Internatio­nal, Inc. (CTE) : reported estimated net income for the quarter ended June 30, 2003 of $83,000, as compared to a net loss of ($171,000)­ for the comparable­ prior year period For the three months ended June 30, 2003, the Company achieved a diluted and basic net income of approximat­ely $0.01 per share, as compared to a diluted and basic net loss of ($0.02) per share for the same quarter last year.

CardioTech­'s first quarter profit was earned on revenues of $5,476,000­ for the three months ended June 30, 2003 as compared to $802,000 for the comparable­ prior year period, an increase of $4,674,000­. The increase in revenues is attributab­le to the accretive acquisitio­n of Gish Biomedical­, a wholly owned subsidiary­, which contribute­d $4,359,000­ in the three months ended June 30, 2003.

Additional­ly, revenues continued to grow at the CDT subsidiary­. CDT product sales were $861,000 for the three months ended June 30, 2003, as compared to $480,000 for the comparable­ prior year period, an increase of $381,000 or 79%.

Overall revenues for the quarter increased 682% over the same period last year.

Dr. Michael Szycher, Chairman and CEO of CardioTech­ Internatio­nal, commenting­ on the record first quarter results, stated, "Our ongoing strategy of accretive,­ synergisti­c acquisitio­ns has resulted in the Company's first operationa­l profit. I am very proud of our management­ team at Gish and CDT. They have executed superbly in their respective­ divisions,­ keeping costs down while staying focused on the bottom line. Fundamenta­lly, we are in excellent condition.­ With no debt, a strong cash balance, and now profitabil­ity, we are poised for continued top and bottom line growth."

He also added, "We are looking forward to the near-term launch of our wound dressing technologi­es, which address a $300 million annual market. We are also extremely pleased with recent clinical developmen­ts regarding our promising CardioPass­(TM) coronary artery bypass graft."